Calcium Phosphate and Incretins

Influence of a Calcium Phosphate Supplementation on the Secretion of Incretins in Humans.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01296997

Enrollment

Registered

2011-02-16

Start date

2010-07-31

Completion date

2010-09-30

Last updated

2012-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Men

Keywords

calcium phosphate, incretins, human study

Brief summary

The study was conducted to investigate the effect of a calcium phosphate supplementation on the secretion of incretins.

Interventions

DIETARY_SUPPLEMENTcalcium phosphate

the subjects consumed for 3 weeks a bread enriched with 1 g pentacalcium phosphate per day

OTHERplacebo

the subjects consumed a bread without pentacalcium phosphate

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

PREVENTION

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

MALE

Age

20 Years to 35 Years

Healthy volunteers

Yes

Inclusion criteria

* healthy men

Exclusion criteria

* intake of dietary supplements and chronic diseases

Design outcomes

Primary

Measure	Time frame
secretion of incretins	3 weeks

Secondary

Measure	Time frame
concentration of minerals in plasma	3 weeks

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026